Der var ingen forskel mellem EVISTA - og placebo- behandlede kvinder i forekomsten af vaginal blødning (pletblødning) eller vaginalt udflåd.
There was no difference between EVISTA and placebo treated women in the incidences of vaginal bleeding (spotting) or vaginal discharge.